Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

Gabbard Praises Trump for Handling Tense Debate with Zelenskyy

February 28, 2025

Trump, Xi and Putin Summit Highlights Major Global and U.S. Headlines

November 19, 2026

U.S. Revokes Temporary Protected Status for Honduran and Nicaraguan Immigrants, Risking Deportation

July 7, 2025

Trump Unable to Dismiss Democratic Members from Federal Oversight Board

May 22, 2025

Chinese National Smuggles ‘Agroterrorism’ Pathogen into U.S. in Boots

June 4, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • Midterms Indicate Voter Desire to Move Past Trump, According to Former Senator
  • Ruby Franke Parole Hearing: Daughter Shari Franke Urges Utah Board to Deny Release
  • Biotech CEO Calls for Fentanyl Biodefense Strategy and Experimental Vaccine
  • Alexander Brothers Sentenced to 30 Years in Federal Sex Trafficking Case
  • Cybersecurity Expert Questions Swift Dismissal of Nationwide Outages
  • California DAs Sue Newsom Over Planned Clemency for 548 Death Row Inmates
  • Poland Blames Russia for Deliberate Provocation Following Missile Strikes on NATO Territory, Resulting in 8 Deaths in Ukraine
  • Uber Parking Launches in 15 Cities with New Reservation Feature
  • Alabama Woman Pleads Guilty to Witness Retaliation Involving Smart Glasses
  • Russia Launches Massive Ukraine Attack, Killing 8; Missiles Land in Poland
  • South Florida Faces Extensive Damage and Ongoing Recovery After Flooding
  • Trump Delays Next Move on Iran Until 2027 Amid Chemical Weapons Denial from Tehran
  • Anthropic Aims to Combat Disease and Drive Revenue Through AI Innovation
  • New Book Explores Unexpected Departures and Lasting Impact
  • Stocks Enter Correction Territory Amid Deepening Tech Sell-off
  • Polar Vortex Disruption Heightens Gas Price Risks in Europe
  • Cyberattacks on European Supermarkets Highlight Refrigeration Vulnerabilities
  • Xi’s Summit with Trump and Putin Highlights China’s Diplomatic Strategy
  • GM’s Former CEO Discusses Succession Planning for Barra’s Replacement
  • New High-Speed Train Will Connect Metropolises in Just 2 Hours
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Saturday, November 21
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » U.S. News » Biotech CEO Calls for Fentanyl Biodefense Strategy and Experimental Vaccine
Biotech CEO Calls for Fentanyl Biodefense Strategy and Experimental Vaccine

Biotech CEO Calls for Fentanyl Biodefense Strategy and Experimental Vaccine

News EditorBy News EditorNovember 21, 2026 U.S. News 5 Mins Read

ARMR Sciences CEO Collin Gage says the United States is addressing the fentanyl crisis too late by focusing mainly on reversing overdoses after they begin. He is urging the incoming Democratic-controlled Congress to pursue a bipartisan biodefense strategy focused on preventing synthetic drug exposure. The company is testing an experimental fentanyl vaccine designed to bind the drug in the bloodstream before it reaches the brain. Gage says the initial priority should be military personnel, police officers and other first responders facing possible exposure.

Article Subheadings
1) A prevention-focused approach to fentanyl
2) Why synthetic drugs are viewed as a distinct biothreat
3) How the experimental vaccine is intended to work
4) A proposed bipartisan priority for Congress
5) Safety, transparency and the personal stakes

A prevention-focused approach to fentanyl

Gage argues that the current response waits until a person is experiencing an overdose before attempting to restore breathing and stabilize the patient. He says the country should also invest in treatments that prevent fentanyl from reaching the brain. The proposed shift would not replace emergency overdose medicine or law enforcement measures. Instead, it would add a preventive tool for people facing an elevated risk of accidental or deliberate exposure.

“If you look at the overdose crisis like any other health crisis, really as a disease, you’ll know the best way to treat a crisis is by preventing it altogether,” Gage said.

Why synthetic drugs are viewed as a distinct biothreat

Gage points to Donald Trump’s designation of illicit fentanyl as a weapon of mass destruction as an important step toward treating synthetic drugs as a biodefense concern. The designation came through an executive order signed in December 2025. Gage says the threat differs from conventional chemical or biological weapons because pharmaceutical-based agents can be produced and distributed rapidly.

He cited fentanyl, carfentanil, nitazenes and medetomidine as emerging synthetic threats. He said production knowledge and illicit distribution networks can create challenges beyond a single location or incident, and that the threat is spreading internationally, although no specific global figures were provided.

How the experimental vaccine is intended to work

ARMR Sciences is conducting a Phase 1/2 clinical trial to examine the safety of its experimental fentanyl vaccine and assess how effectively it blocks synthetic threats from reaching the brain. The approach is designed to bind and sequester fentanyl in the bloodstream before the molecule reaches brain receptors involved in breathing.

Gage said the initial development target is military personnel, particularly special forces members who could face battlefield or bioterror exposure. He compared possible use by border personnel and police officers to wearing a bulletproof vest, or a preventive layer intended to reduce the consequences of unexpected exposure. The trial is still evaluating the product, so its safety and effectiveness for broader use have not been established.

A proposed bipartisan priority for Congress

With a new Democratic-controlled Congress expected to begin work, Gage is calling for synthetic drug defense to become a bipartisan issue. He described the effort as a “red, white and blue” priority because fentanyl affects people across racial, geographic and socioeconomic groups. He wants lawmakers to build on the federal designation of illicit fentanyl and create a coordinated biodefense strategy.

The proposed strategy would focus first on protecting troops and first responders, then potentially expand to high-risk civilian groups such as college students. Gage said expansion should follow clear evidence of safety and transparent communication. The article does not identify legislation adopted by Congress or confirm that incoming lawmakers have endorsed the proposal.

Safety, transparency and the personal stakes

ARMR Sciences has published its full formulation on its website and, according to Gage, intentionally excluded heavy metals. He connected that decision to Robert F. Kennedy Jr.’s broader scrutiny of vaccine ingredients. Gage also praised addiction-treatment reform efforts associated with former Representative Patrick Kennedy, while emphasizing that the experimental product remains subject to clinical evaluation.

Gage said his interest is personal. He reported that his mother struggled with addiction and that he has lost friends to overdoses. He framed the company’s work as an attempt to prevent families from experiencing addiction and fatal exposure.

Key Points
Number Key Point
1 ARMR Sciences is testing an experimental fentanyl vaccine in a Phase 1/2 clinical trial.
2 The proposed treatment is intended to sequester fentanyl in the bloodstream before it reaches the brain.
3 The company is initially focusing on troops and first responders.
4 Gage wants Congress to treat synthetic drug defense as a bipartisan biodefense priority.

Summary

Gage is urging federal lawmakers to complement overdose reversal with preventive measures against fentanyl and other synthetic drugs. His company’s vaccine remains experimental and is being assessed for safety and effectiveness in clinical testing. Broader deployment would depend on trial results, regulatory review and decisions by federal policymakers.

Frequently Asked Questions

What is ARMR Sciences testing?

The company is conducting a Phase 1/2 clinical trial of an experimental fentanyl vaccine to assess safety and its ability to block synthetic threats from reaching the brain.

Who would receive the countermeasure first?

Gage said the initial focus is on special forces, military personnel, police officers, border personnel and other first responders who could face exposure.

What does Gage want the incoming Congress to do?

He wants lawmakers to adopt a bipartisan biodefense strategy that treats illicit fentanyl and emerging synthetic drugs as a national security and public health priority.

Biodefense Congress Drug Policy fentanyl Fentanyl Vaccine first responders Synthetic drugs
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

U.S. News

Ruby Franke Parole Hearing: Daughter Shari Franke Urges Utah Board to Deny Release

5 Mins Read
U.S. News

Alexander Brothers Sentenced to 30 Years in Federal Sex Trafficking Case

5 Mins Read
U.S. News

Cybersecurity Expert Questions Swift Dismissal of Nationwide Outages

5 Mins Read
U.S. News

California DAs Sue Newsom Over Planned Clemency for 548 Death Row Inmates

5 Mins Read
U.S. News

Alabama Woman Pleads Guilty to Witness Retaliation Involving Smart Glasses

7 Mins Read
U.S. News

Polar Vortex Disruption Heightens Gas Price Risks in Europe

7 Mins Read
Journalism Under Siege
Editors Picks

Trump Proposes Self-Deportation for Immigrants with Future Legal Reentry Possibility

April 10, 2025

Steve Ballmer Criticizes Trump Tariffs as ‘Not Good’

April 5, 2025

Tesla in Dallas Airport Parking Lot Vandalized

April 1, 2025

Vance Highlights Trump Administration Achievements at CPAC Opening

February 20, 2025

U.S. and Ukraine Sign Economic Agreement Addressing Natural Resources Amid Ongoing Conflict

April 30, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2026 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.
Go to mobile version